nodes	percent_of_prediction	percent_of_DWPC	metapath
Saprisartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.371	0.406	CbGbCtD
Saprisartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.331	0.361	CbGbCtD
Saprisartan—AGTR1—Losartan—type 2 diabetes mellitus	0.213	0.233	CbGbCtD
Saprisartan—AGTR1—artery—type 2 diabetes mellitus	0.0056	0.265	CbGeAlD
Saprisartan—AGTR1—endothelium—type 2 diabetes mellitus	0.00473	0.224	CbGeAlD
Saprisartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.00217	0.103	CbGeAlD
Saprisartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.00195	0.0921	CbGeAlD
Saprisartan—AGTR1—kidney—type 2 diabetes mellitus	0.0019	0.0902	CbGeAlD
Saprisartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.00186	0.0878	CbGeAlD
Saprisartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.00172	0.0813	CbGeAlD
Saprisartan—AGTR1—liver—type 2 diabetes mellitus	0.0012	0.057	CbGeAlD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCKAR—type 2 diabetes mellitus	0.000447	0.00707	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 signaling events—SRC—type 2 diabetes mellitus	0.000444	0.00702	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.000432	0.00684	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—type 2 diabetes mellitus	0.000425	0.00672	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.000413	0.00653	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.000405	0.0064	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.000398	0.00629	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.000391	0.00619	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—AGTR2—type 2 diabetes mellitus	0.000391	0.00618	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 signaling events—EGFR—type 2 diabetes mellitus	0.000389	0.00616	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	0.000379	0.00599	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—EDNRB—type 2 diabetes mellitus	0.000374	0.00592	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	0.000368	0.00582	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	0.000365	0.00577	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.00036	0.00569	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—type 2 diabetes mellitus	0.000358	0.00567	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	0.000358	0.00566	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	0.000356	0.00563	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.000354	0.0056	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—EDNRA—type 2 diabetes mellitus	0.000353	0.00559	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CASP8—type 2 diabetes mellitus	0.000351	0.00556	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	0.00035	0.00553	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	0.000349	0.00551	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—GHRL—type 2 diabetes mellitus	0.000344	0.00544	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	0.000339	0.00536	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.000329	0.00521	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	0.000329	0.0052	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	0.00032	0.00506	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	0.000319	0.00504	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.000317	0.00501	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	0.000314	0.00496	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.000313	0.00494	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	0.000312	0.00493	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.000306	0.00484	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.0003	0.00474	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.000293	0.00463	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	0.000285	0.00451	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.000284	0.0045	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	0.000281	0.00444	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—type 2 diabetes mellitus	0.000279	0.00441	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.000277	0.00437	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	0.000275	0.00435	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	0.000271	0.00429	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.000271	0.00428	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.000269	0.00426	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—AVP—type 2 diabetes mellitus	0.000268	0.00423	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CASP3—type 2 diabetes mellitus	0.000266	0.0042	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.000262	0.00414	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00026	0.00412	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	0.000258	0.00408	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.000256	0.00405	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—EDN1—type 2 diabetes mellitus	0.000255	0.00403	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.000251	0.00397	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	0.000246	0.00389	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.000244	0.00385	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	0.000242	0.00384	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	0.000242	0.00384	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.000238	0.00377	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.000237	0.00375	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.000233	0.00368	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.000232	0.00367	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.000232	0.00367	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.000231	0.00365	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	0.000231	0.00365	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.000228	0.00361	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCR5—type 2 diabetes mellitus	0.000228	0.0036	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	0.000226	0.00357	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—C3—type 2 diabetes mellitus	0.000222	0.00352	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.000221	0.0035	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	0.000214	0.00339	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—AGT—type 2 diabetes mellitus	0.000211	0.00334	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—type 2 diabetes mellitus	0.000207	0.00328	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	0.000207	0.00327	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000205	0.00325	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.000203	0.00322	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.000203	0.00322	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.000201	0.00318	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.000199	0.00316	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TNF—type 2 diabetes mellitus	0.000193	0.00306	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	0.000191	0.00303	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000191	0.00302	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.00019	0.00301	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000186	0.00294	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000185	0.00293	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000185	0.00292	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000185	0.00292	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.00018	0.00285	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.00018	0.00284	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000179	0.00283	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.000178	0.00282	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000177	0.00279	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000176	0.00278	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCL2—type 2 diabetes mellitus	0.000174	0.00275	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000174	0.00275	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000174	0.00275	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000171	0.0027	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000169	0.00267	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000163	0.00257	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000161	0.00254	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.000157	0.00249	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000153	0.00241	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000152	0.00241	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000149	0.00236	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000147	0.00233	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000142	0.00224	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.000141	0.00222	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000139	0.00219	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000138	0.00219	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000137	0.00217	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000137	0.00216	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000135	0.00213	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000134	0.00211	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000131	0.00207	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.00013	0.00206	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000129	0.00204	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000122	0.00193	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000119	0.00188	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000119	0.00188	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000117	0.00185	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000117	0.00185	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000116	0.00184	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000116	0.00184	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000114	0.0018	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000113	0.00179	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000113	0.00178	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000109	0.00173	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000109	0.00173	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000108	0.00171	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000108	0.00171	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000105	0.00167	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000105	0.00166	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000103	0.00163	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000102	0.00162	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000102	0.00161	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	9.98e-05	0.00158	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	9.98e-05	0.00158	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	9.94e-05	0.00157	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	9.81e-05	0.00155	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	9.8e-05	0.00155	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GIP—type 2 diabetes mellitus	9.61e-05	0.00152	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	9.52e-05	0.00151	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.26e-05	0.00146	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.13e-05	0.00144	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	9.11e-05	0.00144	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.09e-05	0.00144	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.06e-05	0.00143	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.02e-05	0.00143	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	8.94e-05	0.00141	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	8.91e-05	0.00141	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	8.89e-05	0.00141	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	8.72e-05	0.00138	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.49e-05	0.00134	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.25e-05	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.17e-05	0.00129	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.12e-05	0.00128	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	7.89e-05	0.00125	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.83e-05	0.00124	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	7.73e-05	0.00122	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.35e-05	0.00116	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.28e-05	0.00115	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.22e-05	0.00114	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.22e-05	0.00114	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.11e-05	0.00113	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.03e-05	0.00111	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.03e-05	0.00111	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.02e-05	0.00111	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.02e-05	0.00111	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	7e-05	0.00111	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.98e-05	0.0011	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.92e-05	0.00109	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.67e-05	0.00106	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.57e-05	0.00104	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.42e-05	0.00102	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.34e-05	0.001	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.27e-05	0.000992	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.23e-05	0.000985	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.19e-05	0.000979	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.1e-05	0.000965	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.08e-05	0.000962	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.08e-05	0.000961	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.05e-05	0.000957	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.97e-05	0.000944	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—C3—type 2 diabetes mellitus	5.83e-05	0.000922	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.79e-05	0.000916	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.64e-05	0.000892	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.62e-05	0.000889	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.62e-05	0.000889	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.54e-05	0.000876	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.47e-05	0.000865	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.45e-05	0.000862	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.44e-05	0.000861	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.35e-05	0.000847	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.33e-05	0.000843	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.33e-05	0.000843	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.26e-05	0.000833	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.12e-05	0.00081	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.96e-05	0.000784	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.94e-05	0.000781	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.87e-05	0.000771	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.87e-05	0.000771	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.8e-05	0.000759	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.78e-05	0.000756	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.56e-05	0.000722	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.48e-05	0.000709	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.48e-05	0.000708	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.24e-05	0.000671	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.2e-05	0.000665	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.14e-05	0.000656	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.14e-05	0.000656	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.13e-05	0.000653	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.11e-05	0.00065	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.07e-05	0.000643	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.01e-05	0.000634	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.99e-05	0.000631	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.94e-05	0.000624	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.83e-05	0.000605	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.74e-05	0.000592	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.59e-05	0.000568	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.52e-05	0.000557	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—C3—type 2 diabetes mellitus	3.44e-05	0.000545	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.28e-05	0.00052	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.28e-05	0.000518	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.27e-05	0.000518	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.22e-05	0.000509	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.21e-05	0.000507	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.21e-05	0.000507	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.17e-05	0.000501	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.02e-05	0.000478	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.86e-05	0.000452	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	2.74e-05	0.000433	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.69e-05	0.000426	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.65e-05	0.000419	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.65e-05	0.000419	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.64e-05	0.000417	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.52e-05	0.000398	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.4e-05	0.00038	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.4e-05	0.00038	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.26e-05	0.000358	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.06e-05	0.000326	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.04e-05	0.000323	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.03e-05	0.00032	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.93e-05	0.000305	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.91e-05	0.000302	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.87e-05	0.000296	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.78e-05	0.000281	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.73e-05	0.000274	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.59e-05	0.000251	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.56e-05	0.000246	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-05	0.000189	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-05	0.000175	CbGpPWpGaD
